CompletedNCT02332941
Treatment -Resistant Neovascular Age-Related Macular Degeneration
PHASE1 · 5 planned enrolment
- Countries listed
- 1
- Registry update
- June 3, 2015
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–1 of 1. Every record below meets all the filters shown above.
PHASE1 · 5 planned enrolment